MJayawardena

TL3 Regular · Kuopio, FI

Long-standing member. Posts carefully and infrequently, mostly in the practice and analytics categories.

Joined 11 August 2024 · last posted 18h

144 posts, newest first. Showing up to 150.

Coming back to: A structured critique template this community uses Replied, post #70 · Evidence › Study critique · 27 Jul 2026 · 13 likes Everything in post #68 holds. The case it does not cover is the one I have. Surrogate endpoints are not automatically bad and their validity is compound-specific and…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #72 · Access › Insurance & coverage · 26 Jul 2026 · 0 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
About the Independent verification category Replied, post #5 · Sourcing › Independent verification · 24 Jul 2026 · 6 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #116 · Analytics › Home & field testing · 23 Jul 2026 · 7 likes Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work. These are sometimes available commercially but are…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #86 · Compounds › Retatrutide · 23 Jul 2026 · 0 likes Post #84 put the caveat in the right place and I want to underline it. Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of…
What to bring: records that a clinician can actually use — a second dataset Replied, post #62 · Clinical › Prescriber conversations · 21 Jul 2026 · 9 likes A second opinion is a normal part of medicine rather than an accusation, and asking how to obtain one is a legitimate question. Written quickly, so the reasoning may be…
Athletes in weight-category sports: a different risk calculus Replied, post #33 · Clinical › Special populations · 20 Jul 2026 · 7 likes Taking post #30 at face value and following it one step further. The most useful contribution here is usually a citation to whichever published document comes closest,…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #15 · Clinical › Prescriber conversations · 19 Jul 2026 · 10 likes This follows post #12 rather than contradicting it. Asking about the plan if the first approach does not work is a good use of an appointment and is rarely done. This…
Fibre intake when total intake falls, and the constipation link — one year on Replied, post #13 · Nutrition & Training › Protein & intake · 18 Jul 2026 · 0 likes Timing of protein: spreading protein intake across the day, with some at each meal, is more practical than trying to hit the whole target at one sitting on suppressed…
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #3 · Compounds › Oral incretins · 16 Jul 2026 · 0 likes PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading them requires attention to which trial is which because…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #126 · Practice › Reconstitution · 15 Jul 2026 · 0 likes Dead volume is the part nobody mentions until it costs them a dose. A fixed-needle insulin syringe holds very little; a detachable-needle luer configuration can hold…
What steady state means for the decision to escalate Replied, post #25 · Practice › Dosing & titration · 7 Jul 2026 · 0 likes I read the earlier replies on steady state twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #44 · Analytics › Impurities & related substances · 3 Jul 2026 · 12 likes An impurity profile that changes between lots is more informative than the total. A stable profile suggests a controlled process; a shifting one suggests something is…
CJC-1295 with and without DAC: what the modification does Replied, post #99 · Compounds › Secretagogues & GH axis · 1 Jul 2026 · 1 like Post #95 put the caveat in the right place and I want to underline it. Storage: these are lyophilised short peptides and are generally reasonably stable dry and…
Journal club: what we got wrong in an earlier session Replied, post #38 · Evidence › Journal club · 29 Jun 2026 · 9 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. Written…
Talking to a therapist about this specifically Replied, post #14 · Wellbeing › Mental health · 20 Jun 2026 · 23 likes Motivation and expectation: starting with clear motivation and realistic expectations about what will happen and when helps with psychological adjustment.
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #43 · Clinical › Bloodwork · 12 Jun 2026 · 5 likes That is clearer than the version I had in my head. Thank you.
Follow-up: Reading an interaction checker output critically Started this topic · Practice › Interactions · 8 Jun 2026 · 0 likes Reading an interaction checker output critically — setting out what I have, and where I think it stops being reliable. A follow-up question about Reading an interaction…
A pooled estimate that changed when one trial was added Replied, post #7 · Evidence › Meta-analyses · 7 Jun 2026 · 19 likes Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the baseline risk is specified. More interpretable than pooled relative effects.
Tracking a shortage from primary sources rather than rumour Replied, post #35 · Access › Shortages · 4 Jun 2026 · 5 likes Post #34 is right about the mechanism and I think understates the practical bit. Anyone reporting availability should say the region and the date, because both…
A site rotation scheme that is easy enough to actually follow Replied, post #73 · Practice › Administration · 27 May 2026 · 11 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. I…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #93 · Compounds › Tirzepatide · 26 May 2026 · 4 likes Post #90 answers the question as asked. The question underneath it is different. On purity: the trailing-edge features people report on tirzepatide chromatograms are…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #84 · Compounds › Tirzepatide · 24 May 2026 · 32 likes Adding the measurement that post #83 says would settle it. Tirzepatide and nausea is a question about a distribution, not about a value, and treating it as a value is…
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #119 · Practice › Storage & stability · 20 May 2026 · 4 likes Worth separating two things that post #115 runs together. Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or…
Revisiting: Patterns that reliably precede a problem, documented Replied, post #3 · Sourcing › Red flags · 19 May 2026 · 1 like That is clearer than the version I had in my head. Thank you.
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #16 · Analytics › Method validation · 11 May 2026 · 20 likes Specificity is the first question: does the method separate the analyte from everything reasonably expected to be present? A method that has not been challenged with…
The headache that turns out to be dehydration — the long version Replied, post #33 · Nutrition & Training › Hydration & electrolytes · 10 May 2026 · 3 likes Two things can be true about headache at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is people…
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #100 · Research Methods › Statistics · 9 May 2026 · 2 likes Building on post #98 rather than restating it. The most common statistical error in this community is not technical: it is treating a self-selected collection of…
A parcel stationary at a customs facility for nine days — does this still hold? Replied, post #19 · Sourcing › Logistics · 6 May 2026 · 20 likes At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at customs, it might be held or lost. Days of delay…
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #25 · Analytics › COA interpretation · 2 May 2026 · 0 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
The headache that turns out to be dehydration — the long version Replied, post #24 · Nutrition & Training › Hydration & electrolytes · 20 Apr 2026 · 12 likes Post #23 put the caveat in the right place and I want to underline it. Summarising the headache thread so far, since it is long and the answer is buried: the first…
Coming back to: Half-life, steady state, and accumulation worked through Replied, post #16 · Pharmacology › Pharmacokinetics · 14 Apr 2026 · 6 likes Steady state is approached in roughly four to five half-lives. For a compound with a week-long half-life that is four to five weeks, which is where the escalation…
Spike-and-recover accuracy for a peptide assay Replied, post #68 · Analytics › Method validation · 9 Apr 2026 · 14 likes I read post #64 twice before replying, because I had assumed the opposite. System suitability is the ongoing evidence that a validated method is still performing.…
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #26 · Evidence › Journal club · 8 Apr 2026 · 4 likes Seconded. It reads as careful rather than confident, which is the right register.
Sample handling between despatch and injection Replied, post #12 · Analytics › Method validation · 1 Apr 2026 · 22 likes The reason sample handling between despatch keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #86 · Pharmacology › Pharmacokinetics · 28 Mar 2026 · 29 likes Coming back to post #82, because the follow-up matters more than the original answer. Reframing Washout slightly, because I think the disagreement is about the question…
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #64 · Sourcing › Logistics · 28 Mar 2026 · 18 likes That matches what I have seen, for whatever a single anecdote is worth.
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #38 · Sourcing › Vendor reports · 20 Mar 2026 · 16 likes Post #36 answers the question as asked. The question underneath it is different. Comparing your result to somebody else's on a different lot is not a comparison of…
Five questions in one post gets you one answer — how to split them Replied, post #31 · Start Here › How to Ask · 14 Mar 2026 · 0 likes Answering the question post #29 raises rather than the one it answers. Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask…
Whether protein timing matters at a large deficit Replied, post #33 · Nutrition & Training › Protein & intake · 12 Mar 2026 · 6 likes Targets in the literature are usually expressed per kilogram of body mass and are higher during a deficit than at maintenance. Which body mass is used matters.
[2026 update] Distinguishing expected GI effects from something that needs urgent… Replied, post #2 · Practice › Side effects · 11 Mar 2026 · 24 likes Discontinuation for adverse effects in the published trials was not rare at the higher doses. That number belongs in any discussion of tolerability and is usually left…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #139 · Compounds › Semaglutide · 9 Mar 2026 · 17 likes Practical experience of semaglutide half-life, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it…
[2026 update] Composite endpoints and the component doing the work Replied, post #22 · Evidence › Trials · 7 Mar 2026 · 27 likes On post #18 — agreed on the reasoning, with one qualification. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical…
The lowest dose that does anything: is that a real question? Replied, post #55 · Practice › Dosing & titration · 5 Mar 2026 · 0 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
Foaming during reconstitution and whether it matters — the long version Replied, post #46 · Practice › Reconstitution · 26 Feb 2026 · 9 likes Taking post #45 at face value and following it one step further. Foaming during reconstitution looks different depending on whether you are reading the primary…
[2026 update] Confounding by indication, explained with a concrete example Replied, post #69 · Evidence › Study critique · 20 Feb 2026 · 0 likes On post #66 — agreed on the reasoning, with one qualification. Criticism is more useful when it is narrower. "The trial answers a different question from the one being…
Angle of injection and whether 90 degrees is always right Replied, post #101 · Practice › Administration · 16 Feb 2026 · 3 likes Post #99 put the caveat in the right place and I want to underline it. The reason angle of injection keeps being re-asked is that the answer is conditional and people…
Interpreting a result that disagrees with the supplier's certificate Replied, post #119 · Sourcing › Independent verification · 12 Feb 2026 · 1 like The claim about interpreting a result upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
Heterogeneity as information rather than as a nuisance Replied, post #91 · Evidence › Meta-analyses · 5 Feb 2026 · 21 likes High heterogeneity is the finding rather than a nuisance to be minimised. If the effect genuinely differs across settings, an average of those settings is an average of…
Second pass at: The topic list is dense — is that deliberate? Replied, post #60 · Meta › Site feedback · 2 Feb 2026 · 21 likes Post #56 put the caveat in the right place and I want to underline it. That would also be the fastest way for a new member to understand what R6 actually catches, which…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #83 · Access › International · 31 Jan 2026 · 26 likes Small methodological point on Language barriers in accessing: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Specification in the result column: why that is a meaningful error Replied, post #110 · Analytics › COA interpretation · 23 Jan 2026 · 4 likes Taking post #109 at face value and following it one step further. A certificate of analysis is a statement by its issuer that a defined test was performed on a defined…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #68 · Access › International · 22 Jan 2026 · 4 likes Reading back through the Language barriers in accessing threads from last year, the same three questions come up every time and only one of them has ever been answered…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #21 · Clinical › Special populations · 21 Jan 2026 · 18 likes Genetic and ancestry-related differences in response are asked about regularly and the published evidence is thin enough that the honest answer is short.
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #14 · Clinical › Special populations · 21 Jan 2026 · 10 likes I read post #12 twice before replying, because I had assumed the opposite. I would keep Pregnancy and pregnancy planning and the decision it usually gets used for…
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #45 · Regional › UK & Ireland · 7 Jan 2026 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
Reverse causation in a cohort study of weight and outcome Replied, post #8 · Evidence › Study critique · 30 Dec 2025 · 1 like Answering the question post #4 raises rather than the one it answers. What makes a methodological criticism substantive: it identifies a specific feature of the design…
Research-use-only labelling: what it means and what it does not Replied, post #78 · Sourcing › Regulatory · 26 Dec 2025 · 13 likes Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are frequently misreported. That holds for the case as…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #76 · Compounds › Oral incretins · 21 Dec 2025 · 18 likes That is clearer than the version I had in my head. Thank you.
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #13 · Compounds › Oral incretins · 17 Dec 2025 · 0 likes The thirty-minute wait before eating is not conservatism. Food in the stomach materially reduces absorption of the oral product, and the instruction exists because the…
Tracking a preprint to publication: a worked example Replied, post #37 · Evidence › Preprints · 3 Dec 2025 · 0 likes Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
Gastro-oesophageal reflux: improving or worsening? Replied, post #2 · Clinical › Comorbidities · 28 Nov 2025 · 26 likes The arithmetic in the opening post is right; the assumption feeding it is the part to check. The practical version of gastro-oesophageal reflux is three sentences long.…
Non-inferiority margins: how they are chosen and how they are abused Replied, post #19 · Evidence › Trials · 28 Nov 2025 · 9 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #38 · Compounds › Oral incretins · 10 Nov 2025 · 6 likes Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
[2026 update] What steady state means for the decision to escalate Replied, post #21 · Practice › Dosing & titration · 6 Nov 2025 · 0 likes Nothing to add, except that this is the answer I would give if asked.
[2026 update] What steady state means for the decision to escalate Replied, post #18 · Practice › Dosing & titration · 6 Nov 2025 · 15 likes Post #14 describes the usual case. This is about the unusual one. The failure mode on steady state is boring rather than dramatic. It is almost always the step everyone…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #158 · Practice › Reconstitution · 3 Nov 2025 · 17 likes Post #155 is right about the mechanism and I think understates the practical bit. I have been on both sides of the 10 mg vial reconstituted three argument in this…
A parcel that arrived warm: a decision process, not a verdict Replied, post #110 · Practice › Storage & stability · 29 Oct 2025 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. The interesting…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #127 · Compounds › Tirzepatide · 24 Oct 2025 · 5 likes Weight reduction figures from SURMOUNT-1 are frequently quoted without the trial's duration attached. A mean change at 72 weeks and a mean change at 40 weeks are…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #18 · Clinical › Special populations · 23 Oct 2025 · 11 likes Dedicated trials in under-studied populations are the only real remedy and several are ongoing, which is worth saying rather than speculating.
Payment mechanics and the recovery options that do not exist Replied, post #4 · Sourcing › Payments · 18 Oct 2025 · 5 likes Fair, and the limits you put on it are the part I will remember.
Follow-up: Why appetite effects are mostly central Replied, post #67 · Pharmacology › Receptor biology · 14 Oct 2025 · 22 likes Post #64 answers the question as asked. The question underneath it is different. The area postrema sits outside the blood-brain barrier and is where a great deal of the…
Compounds this community declines to help with, and why Replied, post #69 · Compounds › Other compounds · 6 Oct 2025 · 15 likes Post #67 put the caveat in the right place and I want to underline it. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical…
Second pass at: The mass-error checker and its intended scope Replied, post #30 · Data & Tools › Calculators · 3 Oct 2025 · 7 likes Everything in post #28 holds. The case it does not cover is the one I have. The parts-per-million mass-error calculation is simple enough to do mentally to one…
Pinch or no pinch, and how needle length changes the answer Replied, post #69 · Practice › Administration · 19 Sep 2025 · 8 likes Leaving the needle in for a couple of seconds after depressing the plunger reduces leakage at the site. It costs nothing and it is the fix for the "some came back out"…
Payment method and the leverage it gives you, ranked Replied, post #30 · Sourcing › Payments · 18 Sep 2025 · 22 likes I read post #29 twice before replying, because I had assumed the opposite. Cryptocurrency for payment: offers less fraud protection than credit cards and is final like…
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #40 · Lounge › Off topic · 16 Sep 2025 · 2 likes Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion. I…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #114 · Evidence › Study critique · 16 Sep 2025 · 4 likes Narrowing post #112, because the general version has more than one answer. A criticism that would apply equally to every trial in the field is worth stating once and is…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #151 · Data & Tools › Datasets · 11 Sep 2025 · 26 likes Aggregating first-hand accounts does not produce evidence of the kind a trial produces. It produces a description of who chose to post, which is a real thing and a…
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #37 · Analytics › Method validation · 7 Sep 2025 · 1 like The most useful single question about a method: what would it fail to detect? Every method has an answer and few documents state it. A qualification I should have led…
Managing an unplanned gap in supply — what changed since Replied, post #55 · Access › Shortages · 6 Sep 2025 · 0 likes Nothing here is medical advice, and decisions about what to do during a supply interruption belong with a prescriber.
When a preprint is the best available evidence and we say so Replied, post #134 · Evidence › Preprints · 3 Sep 2025 · 9 likes Peer review catches some things reliably — missing methods, unsupported conclusions, statistical mistakes of the obvious kind — and misses others routinely. Knowing…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #114 · Practice › Reconstitution · 28 Aug 2025 · 30 likes I would call the community position on 10 mg vial reconstituted three likely rather than established, and I would be comfortable defending that hedge.
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #104 · Compounds › Secretagogues & GH axis · 27 Aug 2025 · 0 likes Post #100 put the caveat in the right place and I want to underline it. A mass result for a short peptide is more discriminating than for a long one, because a single…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #8 · Evidence › Journal club · 9 Aug 2025 · 5 likes Before the thread moves on from orforglipron phase 2 — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n…
A ten-fold dose error caught before injection — one year on Replied, post #120 · Devices › Syringes & needles · 4 Aug 2025 · 26 likes Barrel size determines resolution and nothing else. A 0.3 mL barrel and a 1 mL barrel deliver the same volume equally well; the smaller one lets you see what you are…
Follow-up: History of disordered eating and why it changes the conversation Replied, post #52 · Clinical › Special populations · 2 Aug 2025 · 0 likes The most useful contribution here is usually a citation to whichever published document comes closest, with a plain statement of how far it is from the question.
What a reversed-phase purity number actually is — the long version Started this topic · Analytics › HPLC & UHPLC · 26 Jul 2025 · 49 likes What a reversed-phase purity number actually is — the long version I have a specific reason for asking rather than idle curiosity, and the context is below. I would…
Thyroid function tests during substantial weight change Replied, post #12 · Clinical › Bloodwork · 23 Jul 2025 · 7 likes A methods point on thyroid function tests during substantial rather than a substantive one: if the comparison is not like for like, the difference you are measuring is…
Substitution between formats during a shortage Replied, post #26 · Access › Shortages · 21 Jul 2025 · 4 likes Anyone reporting availability should say the region and the date, because both determine whether the report is usable.
Counter-ion content and its effect on measured mass Replied, post #97 · Analytics › Mass spectrometry · 20 Jul 2025 · 1 like Noted, and thank you for writing it out rather than summarising it.
Interim analyses and stopping rules — does this still hold? Replied, post #28 · Evidence › Trials · 3 Jul 2025 · 31 likes Everything in post #24 holds. The case it does not cover is the one I have. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not…
Repeatability versus intermediate precision Replied, post #94 · Analytics › Method validation · 29 Jun 2025 · 0 likes Precision has two levels worth distinguishing: repeatability within a run and intermediate precision across days, analysts and instruments. The second is where most…
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #9 · Compounds › Tirzepatide · 28 Jun 2025 · 8 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #39 · Meta › Wiki maintenance · 26 Jun 2025 · 0 likes Careful with that. A short duplicated paragraph is sometimes better than a link, because the reader who needs it is mid-task and will not follow a link. The test is…
Subcutaneous absorption kinetics and site differences Replied, post #11 · Pharmacology › Pharmacokinetics · 26 Jun 2025 · 6 likes I read post #9 twice before replying, because I had assumed the opposite. Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding…
A side-effect grading scheme this community uses, and its limits Replied, post #3 · Practice › Side effects · 24 Jun 2025 · 18 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #129 · Devices › Cold chain · 24 Jun 2025 · 33 likes Domestic refrigeration: most lyophilised peptides are stored at 2–8 °C (35–46 °F). That is standard refrigerator temperature. Check your refrigerator's actual…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #54 · Evidence › Trials · 16 Jun 2025 · 17 likes Speaking only to Comparators chosen for regulatory reasons as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than…
[2026 update] Gastro-oesophageal reflux: improving or worsening? Replied, post #3 · marked as the solution · Clinical › Comorbidities · 16 Jun 2025 · 22 likes The failure mode on Gastro-oesophageal reflux is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple…
What a documentation review can and cannot tell you Replied, post #4 · Sourcing › Independent verification · 12 Jun 2025 · 3 likes No notes. Posting so the count is not one.
Validating a calculator against hand arithmetic — what changed since Replied, post #129 · Data & Tools › Calculators · 12 Jun 2025 · 4 likes No notes. Posting so the count is not one.
Reading a regulatory notice rather than an article about it — what changed since Replied, post #12 · Sourcing › Regulatory · 2 Jun 2025 · 12 likes I read post #10 twice before replying, because I had assumed the opposite. Practical note on Reading a regulatory notice: write down what you expect before you look.…
Follow-up: History of disordered eating and why it changes the conversation Replied, post #16 · Clinical › Special populations · 30 May 2025 · 29 likes This follows post #13 rather than contradicting it. History of disordered eating was covered in the wiki last year and the page has a review date on it, which is a…
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #50 · Sourcing › Independent verification · 30 May 2025 · 0 likes Two claims get bundled together under splitting a vial and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #124 · Compounds › Cagrilintide & amylin analogues · 29 May 2025 · 4 likes Answering the question post #122 raises rather than the one it answers. Native amylin has awkward physical properties — it aggregates readily, which is why a stable…
Second pass at: Semaglutide and alcohol: what is actually documented Replied, post #7 · Compounds › Semaglutide · 28 May 2025 · 0 likes Research-use-only semaglutide is not a licensed medicine, is not manufactured to pharmaceutical standards, and is not approved for human use. That is a statement about…
The storage lookup and where its data comes from Replied, post #2 · Data & Tools › Calculators · 28 May 2025 · 7 likes Reading rather than contributing, but this is the most useful thread I have found on it.
Storing a pen in use versus a pen unopened Replied, post #16 · Devices › Pens & autoinjectors · 26 May 2025 · 3 likes Post #14 and I disagree about the size of the effect, not about the direction. Storage instructions for a pen typically differ before and after first use, and the…
Coming back to: What published stability data actually covers, and what it does not Replied, post #42 · Practice › Storage & stability · 16 May 2025 · 30 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. Flagging that the sources on this are…
Coverage for the indication versus for the drug Replied, post #58 · Access › Insurance & coverage · 8 May 2025 · 27 likes Answering the question post #55 raises rather than the one it answers. Quantity limits are a separate decision from coverage and have their own exception route. Reading…
Deamidation and the close-eluting pair it produces Replied, post #32 · Analytics › Impurities & related substances · 25 Apr 2025 · 2 likes Quietly grateful for the plain phrasing. Not every thread gets that.
Carryover and the ghost peak from last week's standard Replied, post #31 · Analytics › HPLC & UHPLC · 5 Apr 2025 · 28 likes Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of…
A certificate with no method stated: what can you conclude? Replied, post #30 · Analytics › COA interpretation · 5 Apr 2025 · 27 likes Asking for the batch record rather than the certificate is a reasonable request and the response to it is informative whichever way it goes. That holds for the case as…
Counter-ion content and its effect on measured mass Replied, post #10 · marked as the solution · Analytics › Mass spectrometry · 2 Apr 2025 · 27 likes Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to be uninformative. Check when the instrument was last…
Coming back to: An 18-month record including the parts that went badly Replied, post #33 · Outcomes › Progress reports · 30 Mar 2025 · 8 likes Practical note on 18-month record: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would allow.
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #10 · Evidence › Journal club · 15 Mar 2025 · 29 likes Careful with the language on STEP 4. "Not detected" and "not present" are different findings and the first is a statement about the method.
Charge states for a 4 kDa peptide, worked through Replied, post #9 · Analytics › Mass spectrometry · 2 Mar 2025 · 0 likes The arithmetic for a doubly charged species is (M + 2 x 1.00728) / 2, and the analogous expression for higher charge states. Working it through once makes the reported…
Why we hide unevidenced fraud accusations and log the hiding Replied, post #53 · Sourcing › Red flags · 16 Feb 2025 · 12 likes Where somebody posts a concern, ask what would resolve it before arguing about it. Half of these threads end with a document nobody had asked for. If that is already…
UK access routes, dated and sourced — a second dataset Replied, post #38 · Regional › UK & Ireland · 13 Feb 2025 · 8 likes Occupational health screening: some UK occupations require medical checks. Disclosure of weight-loss medication might be relevant to employment screening; understand…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #35 · Evidence › Meta-analyses · 1 Feb 2025 · 0 likes Where I part company with post #33, and it is a narrow parting. Speaking only to Random versus fixed effects as I have actually seen it, rather than as it is usually…
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #51 · Analytics › COA interpretation · 24 Jan 2025 · 15 likes Building on post #48 rather than restating it. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to…
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #46 · Compounds › Oral incretins · 13 Jan 2025 · 16 likes Adding the measurement that post #43 says would settle it. Taking the oral product with more water than instructed reduces absorption rather than helping it. That is…
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #17 · Pharmacology › Receptor biology · 3 Jan 2025 · 6 likes Biased agonism is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
Oxidation pathways for methionine and tryptophan Replied, post #12 · Analytics › Impurities & related substances · 26 Dec 2024 · 0 likes The arithmetic in post #10 is right; the assumption feeding it is the part to check. Careful with the language on oxidation pathways for methionine. "Not detected" and…
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #95 · Compounds › Semaglutide · 24 Dec 2024 · 0 likes Since Molecular mass of semaglutide keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more…
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #50 · Compounds › Semaglutide · 21 Dec 2024 · 26 likes Same experience here, different supplier, so it is at least not unique to one of them.
[2026 update] How to read a forest plot, properly, from scratch Replied, post #50 · Evidence › Trials · 21 Dec 2024 · 1 like Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
Washout with a one-week half-life: the arithmetic Replied, post #75 · Research Methods › N-of-1 designs · 6 Dec 2024 · 4 likes Adding the measurement that post #74 says would settle it. The question underneath washout is usually "how would I tell?" rather than "what is true?", and that one has…
Washout with a one-week half-life: the arithmetic Replied, post #22 · Research Methods › N-of-1 designs · 26 Nov 2024 · 0 likes Building on post #19 rather than restating it. Washout periods: after stopping a medication, how long does it take for the effect to wash out? For compounds with a…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #53 · Compounds › Tirzepatide · 25 Nov 2024 · 28 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #132 · Compounds › Repair & healing peptides · 24 Nov 2024 · 0 likes Answering the question post #130 raises rather than the one it answers. The number people quote for reading a preclinical wound-healing model is a central estimate…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #44 · Compounds › Tirzepatide · 19 Nov 2024 · 0 likes Adding a note of thanks rather than an opinion. I did not know most of that.
Requesting a page: what makes a good request — what changed since Replied, post #48 · Documentation › Wiki requests · 10 Oct 2024 · 15 likes Where I part company with post #46, and it is a narrow parting. I have three months of notes on Requesting a page and the honest summary is that the trend is real and…
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #19 · Wellbeing › Mental health · 6 Oct 2024 · 0 likes If you are in crisis, contact a local emergency or crisis service rather than posting. A volunteer forum cannot help and waiting costs time. Take it as a starting point…
Why I ask for the gradient before I discuss the number Replied, post #20 · Analytics › HPLC & UHPLC · 14 Sep 2024 · 14 likes Where the baseline is drawn is the least documented and most consequential choice in the whole determination. Valley-to-valley, tangent skim and forced-to-zero can span…
The C-cell question: rodent findings and their human context — what changed since Replied, post #44 · Compounds › Semaglutide · 9 Sep 2024 · 0 likes STEP 1 and STEP 4 are two different questions. The first asks what happens when treatment is added; the second asks what happens when it is withdrawn after a run-in.…
Second pass at: Retatrutide dose escalation in the published trials Replied, post #81 · Compounds › Retatrutide · 21 Jul 2024 · 7 likes Post #78 put the caveat in the right place and I want to underline it. Whether triple agonism is additive or synergistic is an open question and the published work does…
Journal club: FLOW and the renal composite, component by component Replied, post #79 · Evidence › Journal club · 16 Jul 2024 · 12 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend.
The mass-error checker and its intended scope Replied, post #119 · Data & Tools › Calculators · 13 Jul 2024 · 1 like Answering the mass-error checker question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #105 · Practice › Dosing & titration · 9 Jul 2024 · 5 likes On Splitting a weekly dose the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #14 · Practice › Dosing & titration · 6 Jul 2024 · 7 likes Post #13 is the version of this I will quote in future. One addition. When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent…
The mass-error checker and its intended scope Replied, post #98 · Data & Tools › Calculators · 5 Jul 2024 · 0 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
How this community labels and discusses unrefereed work Replied, post #39 · Evidence › Preprints · 25 Jun 2024 · 3 likes Author track record is a weak signal and it is a signal. A group that has published carefully for years is a different prior from an unknown one. If the premise is…